Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-ABLE: Musculoskeletal Health in Breast Cancer Patients on Aromatase Inhibitors
NCT03811509Phase 4Unknown
- Sponsor
- Parc de Salut Mar
- Start
- Jan 2016
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Phase 4, open-label trial in osteoporosis (2 arms), sponsored by Parc de Salut Mar. Primary endpoints: Bone mass measured by dual energy x-ray absorptiometry densitometry at 72 months, Fragility fractures assessed by x-ray at 60 months and 2 more. Status: unknown.
02
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT03811509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03811509.